Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma is a research paper published in International Journal of Cancer (2023). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →H2020 European Research Council
Grant: 835227
H2020 European Research Council
Grant: 862580
Israel Cancer Research Fund
Grant: ICRF‐PROF‐18‐682
Israel Science Foundation
Grant: 1969/18
Israel Cancer Research Fund
Grant: ICRF-PROF-18-682
Morris Kahn Foundation
Morris Kahn Foundation
FWCI
0.91
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals